• Join
  • Login
  • Contact

Search abstracts

Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors vs. Dipeptidyl Peptidase-4 Inhibitors in Frail People with Diabetes

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: SAP-062
  • By: ILOMAKI, Jenni (Monash University, Australia)
  • Co-author(s):

    Dr Stephen Wood (Monash University, Parkville, Australia)
    Prof Simon Bell (Monash University, Parkville, Australia)
    Prof Dianna J Magliano
    Prof Jonathan E Shaw
    Prof Matteo Cesari
    Dr Jenni Ilomaki, Senior Lecturer (Monash University, Parkville, Australia)

  • Abstract:

    Background information: Randomised controlled trials and observational studies have found sodium-glucose cotransporter-2 inhibitors (SGLT-2Is) reduce heart failure (HF) hospitalisations and major adverse cardiovascular events (MACE) in general population with type 2 diabetes. However, the effectiveness of SGLT-2Is on cardiovascular outcomes in


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses